financetom
Business
financetom
/
Business
/
Want to invest in luxury? Choose wine over handbags and scotch
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Want to invest in luxury? Choose wine over handbags and scotch
Sep 24, 2021 11:40 AM

If one is looking to invest in luxury products as an asset class, then wine is the asset that will give the best returns. According to the latest data from Knight Frank’s Luxury Investment Index (Q2 2021), investment-grade wine has seen returns better than previous top investments -- luxury handbags and rare whisky.

“Two assets that have been at the helm of the Knight Frank Luxury Investment Index (KFLII) in recent years -- rare bottles of scotch and Hermés handbags -- have relinquished their places at the top of the index, recording negative 12-month growth. Wine is the front-runner in the 12 months to the end of June 2021 with prices rising 13 percent and 119 percent over a 10-year period,” said Andrew Shirley, editor of Luxury Investment Index at Knight Frank.

“Wine is doing really well, not going crazy but growing nicely. There are no signs of over-exuberance,” explained Wine Owners’ Nick Martin who compiles the data for The Knight Frank Fine Wine Icons Index.

“One market that has been doing well this year is Bordeaux. Burgundy, on the other hand, is taking a bit of a breather.”

Also read: Men, not women, drive luxury goods sales in China

While wine has seen the best returns over a 12-month period, it is far outclassed by other investments over a longer 10-year period. Rare whisky posted returns of 483 percent over 10 years, far higher than the runner-up asset class of collectible cars which had a growth of 122 percent over the same period.

Classic cars and luxury watches were the third and second-best asset classes for 12-month investment periods with price increases of 4 and 5 percent, respectively.

Knight Frank Research compiled the data of the prices from Art Market Research (art, coins, furniture, handbags, jewellery and watches), Fancy Color Research Foundation (coloured diamonds), HAGI (cars), Rare Whisky 101 and Wine Owners.

(Edited by : Shoma Bhattacharjee)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US banks shelve $20 billion bailout plan for Argentina, WSJ reports
US banks shelve $20 billion bailout plan for Argentina, WSJ reports
Nov 20, 2025
Nov 20 (Reuters) - A planned $20 billion bailout to Argentina from JPMorgan Chase ( JPM ), Bank of America ( BAC ) and Citigroup ( C/PN ) has been shelved as bankers pivot instead to a smaller, short-term loan package, the Wall Street Journal reported on Thursday, citing sources. ...
US banks shelve $20 billion bailout plan for Argentina, WSJ reports
US banks shelve $20 billion bailout plan for Argentina, WSJ reports
Nov 20, 2025
(Reuters) -A planned $20 billion bailout to Argentina from JPMorgan Chase ( JPM ), Bank of America ( BAC ) and Citigroup ( C/PN ) has been shelved as bankers pivot instead to a smaller, short-term loan package, the Wall Street Journal reported on Thursday, citing sources. In October, the U.S. Treasury tied up a $20 billion exchange-rate stabilization agreement...
BRIEF-Epsilon Announces The Issuance Of Contingent Shares As Consideration For The Acquisition Of Peak Blm Lease Llc
BRIEF-Epsilon Announces The Issuance Of Contingent Shares As Consideration For The Acquisition Of Peak Blm Lease Llc
Nov 20, 2025
Epsilon Energy Ltd ( EPSN ): * EPSILON ANNOUNCES THE ISSUANCE OF CONTINGENT SHARES AS CONSIDERATION FOR THE ACQUISITION OF PEAK BLM LEASE LLC Source text: Further company coverage: ...
United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing
United Therapeutics Insider Sold Shares Worth $3,789,373, According to a Recent SEC Filing
Nov 20, 2025
04:40 PM EST, 11/20/2025 (MT Newswires) -- Martine A Rothblatt, Director, Chairperson & CEO, on November 18, 2025, sold 8,000 shares in United Therapeutics ( UTHR ) for $3,789,373. Following the Form 4 filing with the SEC, Rothblatt has control over a total of 644,489 common shares of the company, with 130 shares held directly and 644,359 controlled indirectly. SEC...
Copyright 2023-2026 - www.financetom.com All Rights Reserved